Next Article in Journal / Special Issue
Characterization and Application of a Disposable Rotating Bed Bioreactor for Mesenchymal Stem Cell Expansion
Previous Article in Journal / Special Issue
Trends in Upstream and Downstream Process Development for Antibody Manufacturing
Article Menu

Export Article

Open AccessArticle
Bioengineering 2014, 1(4), 213-230; doi:10.3390/bioengineering1040213

An Integrated Downstream Process Development Strategy along QbD Principles

1
Research Center of Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria
2
Institute of Biochemical Engineering, Vienna University of Technology, Gumpendorferstrasse 1A/166-4, 1060 Vienna, Austria
3
BIRD-C GmbH & CoKEG, Erne-Seder-Gasse 4, 1030 Vienna, Austria
*
Author to whom correspondence should be addressed.
Received: 31 July 2014 / Revised: 18 September 2014 / Accepted: 17 October 2014 / Published: 24 October 2014
(This article belongs to the Special Issue Biopharmaceutical Process Development)
View Full-Text   |   Download PDF [939 KB, uploaded 24 October 2014]   |  

Abstract

The development, optimization, and analysis of downstream processes are challenged by a high number of potentially critical process parameters that need to be investigated using lab-scale experiments. These process parameters are spread across multiple unit operations and potentially show interactions across unit operations. In this contribution, we present a novel strategy for bioprocess development that considers the risk of parameter interactions across unit operations for efficient experimental design. A novel risk assessment tool (interaction matrix) is introduced to the Quality by Design (QbD) workflow. Using this tool, the risk of interaction across unit operations is rated. Subsequently, a design of experiments (DoE) across unit operations is conducted that has the power to reveal multivariate interdependencies. The power of the presented strategy is demonstrated for protein isolation steps of an inclusion body process, focusing on the quality attribute inclusion body purity. The concentration of Triton X-100 in the course of inclusion body (IB) purification was shown to interact with the g-number of the subsequent centrifugation step. The presented strategy targets a holistic view on the process and allows handling of a high number of experimental parameters across unit operations using minimal experimental effort. It is generically applicable for process development along QbD principles. View Full-Text
Keywords: quality by design; process development; interaction across unit operations; design of experiments; risk assessment; inclusion body purity quality by design; process development; interaction across unit operations; design of experiments; risk assessment; inclusion body purity
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Meitz, A.; Sagmeister, P.; Langemann, T.; Herwig, C. An Integrated Downstream Process Development Strategy along QbD Principles. Bioengineering 2014, 1, 213-230.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Bioengineering EISSN 2306-5354 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top